La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Healthia Gestion
Gestion contrôle des critères 3/4
Healthia's CEO is Wes Coote, appointed in Apr 2019, has a tenure of 4.67 years. total yearly compensation is A$660.60K, comprised of 60.2% salary and 39.8% bonuses, including company stock and options. directly owns 1.42% of the company’s shares, worth A$3.58M. The average tenure of the management team and the board of directors is 1.4 years and 5.6 years respectively.
Informations clés
Wes Coote
Directeur général
AU$660.6k
Rémunération totale
Pourcentage du salaire du PDG | 60.2% |
Durée du mandat du directeur général | 4.7yrs |
Propriété du PDG | 1.4% |
Durée moyenne d'occupation des postes de direction | 1.4yrs |
Durée moyenne du mandat des membres du conseil d'administration | 5.6yrs |
Mises à jour récentes de la gestion
Recent updates
Calculating The Fair Value Of Healthia Limited (ASX:HLA)
Jan 30Healthia (ASX:HLA) Has Re-Affirmed Its Dividend Of AU$0.02
Mar 02Here's Why Healthia Limited's (ASX:HLA) CEO May Deserve A Raise
Nov 09Earnings Tell The Story For Healthia Limited (ASX:HLA) As Its Stock Soars 30%
Sep 17Healthia Limited (ASX:HLA) Stocks Shoot Up 30% But Its P/E Still Looks Reasonable
Sep 17Healthia (ASX:HLA) Is Increasing Its Dividend To AU$0.025
Sep 01I Ran A Stock Scan For Earnings Growth And Healthia (ASX:HLA) Passed With Ease
Aug 17Is Now An Opportune Moment To Examine Healthia Limited (ASX:HLA)?
May 19Is Healthia (ASX:HLA) A Risky Investment?
Apr 19With EPS Growth And More, Healthia (ASX:HLA) Is Interesting
Apr 03Announcing: Healthia (ASX:HLA) Stock Increased An Energizing 108% In The Last Year
Mar 19Insider Buying: The Healthia Limited (ASX:HLA) Independent Non-Executive Director Just Bought 4.7% More Shares
Mar 06What Kind Of Shareholders Hold The Majority In Healthia Limited's (ASX:HLA) Shares?
Feb 26Is There Now An Opportunity In Healthia Limited (ASX:HLA)?
Feb 09Healthia Limited's (ASX:HLA) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
Jan 19Why Dividend Hunters Love Healthia Limited (ASX:HLA)
Dec 29Did You Miss Healthia's (ASX:HLA) 13% Share Price Gain?
Dec 10We're Not So Sure You Should Rely on Healthia's (ASX:HLA) Statutory Earnings
Nov 20Analyse de la rémunération des PDG
Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
---|---|---|---|
Jun 30 2023 | AU$661k | AU$398k | AU$5m |
Mar 31 2023 | n/a | n/a | AU$3m |
Dec 31 2022 | n/a | n/a | AU$781k |
Sep 30 2022 | n/a | n/a | -AU$1m |
Jun 30 2022 | AU$516k | AU$345k | -AU$3m |
Mar 31 2022 | n/a | n/a | -AU$2m |
Dec 31 2021 | n/a | n/a | AU$161k |
Sep 30 2021 | n/a | n/a | AU$3m |
Jun 30 2021 | AU$400k | AU$306k | AU$5m |
Mar 31 2021 | n/a | n/a | AU$6m |
Dec 31 2020 | n/a | n/a | AU$7m |
Sep 30 2020 | n/a | n/a | AU$5m |
Jun 30 2020 | AU$313k | AU$225k | AU$3m |
Mar 31 2020 | n/a | n/a | AU$1m |
Dec 31 2019 | n/a | n/a | AU$271k |
Sep 30 2019 | n/a | n/a | -AU$483k |
Jun 30 2019 | AU$226k | AU$176k | -AU$1m |
Rémunération vs marché: Wes's total compensation ($USD439.78K) is about average for companies of similar size in the Australian market ($USD622.80K).
Rémunération et revenus: Wes's compensation has been consistent with company performance over the past year.
PDG
Wes Coote
4.7yrs
Titularisation
AU$660,599
Compensation
Mr. Wesley James Coote, also known as Wes, B.Com., C.A., ACIS, serves as the Managing Director of Evolve Salons Limited. Mr. Coote has been Group Managing Director, Chief Executive Officer and Director at...
Équipe de direction
Nom | Position | Titularisation | Compensation | Propriété |
---|---|---|---|---|
Group MD | 4.7yrs | AU$660.60k | 1.42% A$ 3.6m | |
Group Chief Financial Officer | less than a year | AU$319.83k | pas de données | |
Director of Podiatry & Executive Director | no data | AU$115.34k | 6.4% A$ 16.1m | |
Group Chief Partnerships Officer & Executive Director | less than a year | AU$391.84k | 0.75% A$ 1.9m | |
CEO of Eyes & Ears Division and Director | 2.7yrs | AU$368.92k | 3.66% A$ 9.2m | |
Chief Executive Officer of Bodies | less than a year | AU$314.24k | pas de données | |
Chief Technology Officer | 1.9yrs | AU$261.49k | 2.49% A$ 6.3m | |
General Counsel & Company Secretary | 1.8yrs | pas de données | pas de données | |
Group Chief Business Development & Strategy Officer | no data | AU$341.32k | 0% A$ 0 | |
Group Chief Education & Research Officer | no data | pas de données | pas de données | |
Chief Operating Officer of Eyes & Ears Division | less than a year | pas de données | pas de données |
1.4yrs
Durée moyenne de l'emploi
Gestion expérimentée: HLA's management team is not considered experienced ( 1.4 years average tenure), which suggests a new team.
Membres du conseil d'administration
Nom | Position | Titularisation | Compensation | Propriété |
---|---|---|---|---|
Group MD | 4.7yrs | AU$660.60k | 1.42% A$ 3.6m | |
Director of Podiatry & Executive Director | 5.6yrs | AU$115.34k | 6.4% A$ 16.1m | |
Group Chief Partnerships Officer & Executive Director | 1.7yrs | AU$391.84k | 0.75% A$ 1.9m | |
CEO of Eyes & Ears Division and Director | 2.7yrs | AU$368.92k | 3.66% A$ 9.2m | |
Non-Executive Chairman | 5.6yrs | AU$130.00k | 5.67% A$ 14.3m | |
Independent Non-Executive Director | 5.6yrs | AU$80.00k | 2.51% A$ 6.3m | |
Independent Non-Executive Director | 5.6yrs | AU$80.00k | 0.034% A$ 85.2k |
5.6yrs
Durée moyenne de l'emploi
Conseil d'administration expérimenté: HLA's board of directors are considered experienced (5.6 years average tenure).